Format

Send to

Choose Destination
Antivir Ther. 2004 Dec;9(6):1003-11.

Increased sensitivity of SARS-coronavirus to a combination of human type I and type II interferons.

Author information

1
Department of Exerimental Medicine and Pathology--Virology section, University La Sapienza, Rome, Italy.

Abstract

There is currently an urgent need to identify effective antiviral agents that will prevent and treat severe acute respiratory syndrome coronavirus (SARS-CoV) infection. In this study, we have investigated and compared the antiviral effect of different interferons (IFNs) on SARS-CoV replication in the epithelial kidney monkey Vero cell line. The results showed that SARS-CoV grown in Vero cells is moderately sensitive to IFN-beta and only weakly sensitive to IFN-alpha and IFN-gamma, in comparison to other IFN-sensitive viruses, such as those for encephalomyocarditis, vesicular stomatitis and Newcastle disease. Simultaneous incubation of Vero cells with IFN-beta and IFN-gamma indicated that they may act synergistically against SARS-CoV replication. The IFN-induced MxA protein was detected in the IFN-treated Vero cells. The data, however, suggest that the antiviral activity of IFN against SARS-CoV virus is independent of MxA expression.

PMID:
15651759
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center